https://www.live-feeds.com/feed/use-of-glp-1s-like-ozempic-is-forcing-food-companies-to-adaptContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/use-of-glp-1s-like-ozempic-is-forcing-food-companies-to-adapthttps://www.live-feeds.com/feed/use-of-glp-1s-like-ozempic-is-forcing-food-companies-to-adapt#u77330Sun, 20 Sep 2026 10:31:15 +0000The rising popularity of GLP-1 medications like Ozempic forces global food companies and major retailers to rethink their product strategies. A recent Brand Finance report indicates that these weight-loss drugs place billions of dollars in top food brand value at risk. Companies such as PepsiCo are actively flagging these treatments as substantial brand mix risks. Meanwhile, industry observers note that newer weight-loss pills may curb snacking habits differently than injectable drugs, potentially altering the commercial impact on food sales.Why it mattersPharmaceutical weight-loss treatments